7-6005918-C-A

Variant summary

Our verdict is Pathogenic. The variant received 13 ACMG points: 14P and 1B. PM5PP3_StrongPP5_Very_StrongBS1_Supporting

The NM_001406866.1(PMS2):​c.323G>T​(p.Ser108Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000282 in 1,610,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S108N) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00029 ( 0 hom. )

Consequence

PMS2
NM_001406866.1 missense

Scores

15
3

Clinical Significance

Likely pathogenic reviewed by expert panel P:50O:1

Conservation

PhyloP100: 7.54

Publications

85 publications found
Variant links:
Genes affected
PMS2 (HGNC:9122): (PMS1 homolog 2, mismatch repair system component) The protein encoded by this gene is a key component of the mismatch repair system that functions to correct DNA mismatches and small insertions and deletions that can occur during DNA replication and homologous recombination. This protein forms heterodimers with the gene product of the mutL homolog 1 (MLH1) gene to form the MutL-alpha heterodimer. The MutL-alpha heterodimer possesses an endonucleolytic activity that is activated following recognition of mismatches and insertion/deletion loops by the MutS-alpha and MutS-beta heterodimers, and is necessary for removal of the mismatched DNA. There is a DQHA(X)2E(X)4E motif found at the C-terminus of the protein encoded by this gene that forms part of the active site of the nuclease. Mutations in this gene have been associated with hereditary nonpolyposis colorectal cancer (HNPCC; also known as Lynch syndrome) and Turcot syndrome. [provided by RefSeq, Apr 2016]
PMS2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Lynch syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • ovarian cancer
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 13 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr7-6005918-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 91301.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.949
PP5
Variant 7-6005918-C-A is Pathogenic according to our data. Variant chr7-6005918-C-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 9245.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000294 (429/1458548) while in subpopulation NFE AF = 0.000358 (398/1111820). AF 95% confidence interval is 0.000328. There are 0 homozygotes in GnomAdExome4. There are 187 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001406866.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PMS2
NM_000535.7
MANE Select
c.137G>Tp.Ser46Ile
missense
Exon 2 of 15NP_000526.2
PMS2
NM_001406866.1
c.323G>Tp.Ser108Ile
missense
Exon 3 of 16NP_001393795.1
PMS2
NM_001322014.2
c.137G>Tp.Ser46Ile
missense
Exon 2 of 15NP_001308943.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PMS2
ENST00000265849.12
TSL:1 MANE Select
c.137G>Tp.Ser46Ile
missense
Exon 2 of 15ENSP00000265849.7
PMS2
ENST00000382321.5
TSL:1
c.137G>Tp.Ser46Ile
missense
Exon 2 of 11ENSP00000371758.4
PMS2
ENST00000406569.8
TSL:1
n.137G>T
non_coding_transcript_exon
Exon 2 of 13ENSP00000514464.1

Frequencies

GnomAD3 genomes
AF:
0.000164
AC:
25
AN:
152222
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000163
AC:
40
AN:
245780
AF XY:
0.000164
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000282
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000294
AC:
429
AN:
1458548
Hom.:
0
Cov.:
31
AF XY:
0.000258
AC XY:
187
AN XY:
725594
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33404
American (AMR)
AF:
0.000224
AC:
10
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86164
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52302
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.000358
AC:
398
AN:
1111820
Other (OTH)
AF:
0.000349
AC:
21
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000164
AC:
25
AN:
152222
Hom.:
0
Cov.:
33
AF XY:
0.000108
AC XY:
8
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41456
American (AMR)
AF:
0.000327
AC:
5
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68048
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000216
Hom.:
0
Bravo
AF:
0.000128
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000214
AC:
1
ExAC
AF:
0.000128
AC:
15
EpiCase
AF:
0.000218
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions as Germline
Significance:Likely pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
16
-
-
not provided (16)
12
-
-
Lynch syndrome 4 (12)
5
-
-
Hereditary cancer-predisposing syndrome (5)
5
-
-
Lynch syndrome (5)
1
-
-
Breast and/or ovarian cancer (1)
1
-
-
Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9 (1)
1
-
-
Endometrial carcinoma (1)
1
-
-
Hereditary nonpolyposis colorectal neoplasms (1)
1
-
-
Inherited MMR deficiency (Lynch syndrome) (1)
1
-
-
Lynch syndrome 1 (2)
1
-
-
Lynch syndrome 4;C5436817:Mismatch repair cancer syndrome 4 (1)
1
-
-
Mismatch repair cancer syndrome 1 (1)
1
-
-
Mismatch repair cancer syndrome 4 (1)
1
-
-
Pituitary carcinoma (1)
1
-
-
PMS2-related cancer disorders (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.39
CADD
Pathogenic
30
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.80
D
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.98
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.31
D
MetaRNN
Pathogenic
0.95
D
MetaSVM
Pathogenic
0.89
D
MutationAssessor
Pathogenic
4.3
H
PhyloP100
7.5
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-5.2
D
REVEL
Pathogenic
0.94
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.98
MVP
0.98
MPC
0.29
ClinPred
0.97
D
GERP RS
5.7
Varity_R
0.99
gMVP
0.83
Mutation Taster
=3/97
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121434629; hg19: chr7-6045549; COSMIC: COSV56151410; API